Wednesday, May 16, 2018

Imprimis Pharmaceuticals Announces First Quarter 2018 Results

PR Newswire (press release)-17 hours ago
The company's flexible business model allows a drug to be compounded or developed as an FDA-approved product through one of its subsidiaries or ...
Post a Comment